Company intelligence / Profile preview
Vivaldi Biosciences
Fort Collins, Colorado, USAvivaldibiosciences.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Vivaldi Biosciences develops deltaFLU, a universal intranasal influenza vaccine based on deletion of the NS1 gene from the influenza virus. This approach yields a replication-deficient, live attenuated vaccine that induces strong interferon responses and broad cross-protection against diverse strains. Four completed clinical studies show deltaFLU to be safe and immunogenic in adults. Nonclinical data demonstrate superior protection versus licensed vaccines against mismatched strains. The company has also established a rapid, high-yield cell-based manufacturing process using Vero cells.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Live attenuated vaccineProphylactic vaccineFusion proteinMultivalent vaccineVaccine
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Vivaldi Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vivaldi Biosciences.